Oct. 03, 2019 |
|
April. 16, 2024 |
|
jRCTs031190109 |
Ascorbic acid treatment for childhood Charcot-Marie-Tooth disease 1A (Ascorbic acid for CMT1A) |
|
Ascorbic acid treatment for childhood Charcot-Marie-Tooth disease 1A (Ascorbic acid treatment for childhood CMT 1A) |
SHIOHAMA TADASHI |
||
Chiba University Hospital |
||
1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, JAPAN |
||
+81-43-226-2144 |
||
asuha_hare@chiba-u.jp |
||
SHIOHAMA TADASHI |
||
Chiba University Hospital |
||
1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, JAPAN |
||
+81-43-226-2144 |
||
asuha_hare@chiba-u.jp |
Not Recruiting |
Oct. 03, 2019 |
||
Oct. 25, 2019 | ||
12 | ||
Interventional |
||
single arm study |
||
open(masking not used) |
||
uncontrolled control |
||
single assignment |
||
treatment purpose |
||
1. Children under 18 years of age with confirmed PMP22 duplication in genetic testing. |
||
1. The patient has already taken daily vitamin treatment. |
||
No limit | ||
18age old not | ||
Both |
||
Charcot-Marie-Tooth disease type 1A |
||
ascorbic acid dayly intake |
||
CMT1A |
||
ascorbic acid |
||
G600 |
||
CMT score |
||
Electrophysiological examination, Six minutes walking distance |
Chiba University Certified Clinical Research Review Board | |
1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, Japan, Chiba | |
+81-43-226-7171 |
|
prc-jim@chiba-u.jp | |
Approval | |
Sept. 02, 2019 |
No |
|
none |